| SWOG/ Support |
STUDY | R E G |
O P E N |
ARM | ACCR. GOAL |
TOTAL REGS. |
REGS. LAST 12 Month |
REGS. LAST 6 Month |
REGS. LAST 3 Month |
REGS. LAST 30 DAYS |
REGS. LAST 7 DAYS |
DATE OF FIRST REG. |
# of ACT. INSTs |
# of CURR IRBs |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SWOG | S2007-Breast, Brain Mets, Sacituzumab Govitecan | 1 | Y | 1 Sacituzumab Govitecan | 44 | 24 | 3 | 1 | 0 | 0 | 0 | 06/08/2021 | 175 | 55 |
| 24 | 3 | 1 | 0 | 0 | 0 | |||||||||
| S2206-Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 1 | Y | 1 Tissue for MammaPrint testing | 960 | 125 | 125 | 118 | 74 | 26 | 5 | 11/27/2023 | 324 | 107 | |
| 125 | 125 | 118 | 74 | 26 | 5 | |||||||||
| 2 | Y | 2 SOC Chemotherapy | 16 | 16 | 16 | 12 | 3 | 0 | 11/27/2023 | |||||
| 3 SOC Chemotherapy + Durvalumab | 16 | 16 | 16 | 12 | 3 | 1 | ||||||||
| 32 | 32 | 32 | 24 | 6 | 1 | |||||||||
| S2212-Breast, TNBC, Neoadj Chemo + Pembro | 1 | Y | 1 Carbo + Paclitaxel + Pembro -> AC + Pembro | 2400 | 111 | 111 | 91 | 52 | 17 | 4 | 09/15/2023 | 303 | 125 | |
| 2 Carbo + Docetaxel + Pembro | 110 | 110 | 89 | 55 | 17 | 3 | ||||||||
| 221 | 221 | 180 | 107 | 34 | 7 | |||||||||
| Yes | A011801-BRST, HER2+, T-DM1+Placebo v T-DM1+Tucatinib | 1 | E | Total Registrations | 44 | 15 | 4 | 2 | 0 | 0 | 03/11/2021 | 426 | 202 | |
| 44 | 15 | 4 | 2 | 0 | 0 | |||||||||
| A012103-Breast,StgT1cN1-2/T2-4N0-2,obsvsPembrolizumab | 1 | E | Total Registrations | 8 | 8 | 4 | 3 | 0 | 0 | 08/24/2023 | 354 | 170 | ||
| 8 | 8 | 4 | 3 | 0 | 0 | |||||||||
| MA39-BREAST, Node-Pos, Reg RT vs No Reg RT | 1 | E | Total Registrations | 33 | 14 | 11 | 4 | 3 | 1 | 10/18/2019 | 380 | 146 | ||
| 33 | 14 | 11 | 4 | 3 | 1 | |||||||||
| 2 | E | Total Registrations | 32 | 13 | 10 | 4 | 3 | 1 | 10/18/2019 | |||||
| 32 | 13 | 10 | 4 | 3 | 1 | |||||||||
| NRGBR002-Brst, OMBC, II-III, SoC +/- SBRT and/or SA | 1 | T | Total Registrations | 1 | 0 | 0 | 0 | 0 | 0 | 09/22/2017 | 143 | 55 | ||
| 1 | 0 | 0 | 0 | 0 | 0 | |||||||||
| NRGBR005-Br, Stg II&IIIA, Post NAdj Chemo Br Conserv | 1 | T | Total Registrations | 7 | 0 | 0 | 0 | 0 | 0 | 06/22/2018 | ||||
| 7 | 0 | 0 | 0 | 0 | 0 | |||||||||
| No | EA1211-Breast, HER2+, NeoAdj Therapy | 1 | E | Total Registrations | 2 | 2 | 2 | 2 | 1 | 0 | 05/06/2024 | 1 | 3 | |
| 2 | 2 | 2 | 2 | 1 | 0 | |||||||||
| NRGBR007-Breast, Stg I, De-Escalation of Breast RT | 1 | E | Total Registrations | 9 | 4 | 1 | 1 | 0 | 0 | 06/01/2022 | 374 | 166 | ||
| 9 | 4 | 1 | 1 | 0 | 0 | |||||||||
| 2 | E | Total Registrations | 9 | 4 | 1 | 1 | 0 | 0 | 06/01/2022 | |||||
| 9 | 4 | 1 | 1 | 0 | 0 | |||||||||
| NRGBR009-Breast, EarlyStg, Adjuvant Chemo | 1 | E | Total Registrations | 5 | 5 | 5 | 2 | 2 | 0 | 01/31/2024 | 427 | 166 | ||
| 5 | 5 | 5 | 2 | 2 | 0 | |||||||||
| 2 | E | Total Registrations | 4 | 4 | 4 | 1 | 1 | 0 | 01/31/2024 | |||||
| 4 | 4 | 4 | 1 | 1 | 0 | |||||||||